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Intravenous glucose tolerance testThe aim of the study was develop to an animal model that links coping style to insulin resistance. We
hypothesized that the psychogenetically selected Roman Low Avoidance (RLA) rats may serve as such a
model. To test this hypothesis, we submitted both RLA and Roman High avoidance (RHA) rats to a series of
intravenous glucose tolerance tests (IVGTT). These IVGTT were followed by post mortem metabolic
characterization of the selection lines. It was found that plasma insulin levels are markedly elevated in the
passively coping RLA rat, both in baseline conditions and during the intravenous glucose tolerance tests. The
elevation in plasma insulin was accompanied with increased levels of plasma corticosterone, FFA, leptin and
triglycerides but not by changes in body weight. We conclude that the passive, highly emotional RLA rat is
metabolically different from both the RHA rat and the standard control Wistar rat and may serve as a non-
obese animal model for insulin resistance.
© 2009 Elsevier Inc. All rights reserved.1. Introduction
Most animal models for the metabolic syndrome, insulin resis-
tance, and type 2 diabetes are based upon an obese phenotype. This is
consistent with the idea that obesity is one of themajor risk factors for
the development of these metabolic disorders. A signiﬁcant propor-
tion of type 2 diabetes patients, however, never suffered from overt
overweight during the development of the disease.
Psychosocial stress factors, such as a low level of education, a low
sense of coherence, work stress and sleep disorders are also associated
with the development of the metabolic syndrome and insulin
resistance [1]. Personality plays a role as well, as indicated by the
observation in children [2] and adults [3] that a type A personality has
a lower risk to develop the metabolic syndrome. However, animal
studies on this topic are scarce. To our knowledge, there is no animal
study that links psychosocial factors or personality to the develop-
ment of insulin resistance or the metabolic syndrome. In human
studies, patterns of individual characteristics have been generally
grouped into types, temperaments or personalities. In rat studies, we
use the term coping style to refer to a similar distribution.
Studies with the Roman LowandHigh Avoidance rat selection lines
may ﬁll in this gap. Roman Low and High Avoidance rats (RLA andinology, University of Gronin-
31 50 363 2345; fax: +31 50
ll rights reserved.RHA, respectively) were originally selected and bred (from a Wistar
stock) for rapid versus poor acquisition of a two-way, active avoidance
response in the shuttle-box. The poor performance of the RLA rats was
later shown to be due to their increased emotional responsiveness, in
particular their innate tendency to freeze when confronted with a
challenging situation [4]. The behavioral and physiological character-
istics of these selection lines are well documented (for a review, see
[4]). In short, Roman Low Avoidance and Roman High Avoidance rats
differ in emotional reactivity and coping style. RLA rats are highly
emotional individuals with a passive coping style, whereas RHA rats
behave as active individuals with low emotional reactivity. Experi-
mentally, emotionality can be deﬁned as a reaction to environmental
changes characterized by at least two of the following behavioral
parameters: decrease exploratory activity in a novel environment,
increased duration of the freezing response, shorter latency to self-
grooming, or increased defecation [4]. These behavioral responses are
also associated with enhanced HPA-axis reactivity, e.g. corticosterone
secretion [5]. RHA rats are impulsive and show high levels of novelty
seeking behavior [6]. Furthermore, they display rigid behavioral
patterns and they have a greater preference for rewarding substances
as compared to the RLAs [7]. These differences in coping style are
accompanied with differences in several neuroendocrine and meta-
bolic parameters. Most studies focus on neurotransmitters such as
dopamine, serotonin and vasopressin [8,9]. But is was also found that
the RLA rat is characterized by an increased sensitivity of the
hypothalamus-pituitary-adrenal (HPA) axis, leading to increased
corticosterone and corticotrophin (ACTH) secretion [5,10,11].
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high fat diet than the RHA rat and that there were differences in meal
patterns between the selection lines [12].
Increased HPA-axis activity and enhancedweight gain on a high fat
diet generally correlate with changes insulin sensitivity [13–18]. We
therefore hypothesized that the Roman Low and High selection lines
might also be metabolically different, particularly in the regulation of
insulin release and glucose homeostasis. To test this hypothesis, we
submitted both RLA and RHA rats to a series of in vivo intravenous
glucose tolerance tests (IVGTT) to study the glucose and insulin
responses. These IVGTT were followed by a post mortem metabolic
characterization of the selection lines. The data revealed that the
passive, high emotional RLA rat is metabolically different from both
the RHA rat and the standard control Wistar rat and may serve as a
(non-obese) animal model for insulin resistance.
2. Materials and methods
2.1. Animals
Male Roman High Avoidance rats and Roman Low Avoidance rats,
weighing 250–300 g at the beginning of the study, were used. The
animals were obtained from a breeding colony at the Clinical
Psychopharmacology Unit (APSI), University of Geneva, Switzerland.
Before the experiments started rats were given sufﬁcient time (at least
3 weeks) for acclimatization. The animals were individually housed in
standard cages (24×24×36 cm), lab chow (Hope Farms, RMH-B
knaagdier korrel, Arie Block Diervoeding, Woerden, NL) and water was
available ad lib. The room was controlled for temperature and
humidity (T=20±2 °C, humidity 60%) and was kept on a 12–12 h
light–dark cycle (lights on=CT0, lights off=CT12). All animal
experiments were approved by the local animal care committee.
2.2. Experimental design
The study consisted of a series of experiments, which started with
a defensive bury test to deﬁne the coping style of the individual rats.
Then the rats underwent surgery to place indwelling jugular vein
catheters allowing continuous blood sampling in freely moving
animals. After recovery, baseline measurements of food and water
intake and body weight were taken for four weeks. Thereafter two
intravenous glucose tolerance tests (IVGTT) with different doses of
glucose were performed at a two weeks interval. The animals were
sacriﬁced for post mortem carcass and hormone analysis two weeks
after the last IVGTT.
2.3. Defensive burying test
A defensive bury test was performed to verify the coping style of
the rats. The defensive burying test is a coping style test that is
independent of the active avoidance selection paradigm. The
procedurewas ﬁrst described by Pinel and Treit [17]. The experimental
animals were housed in specialized defensive burying cages
(24×24×36 cm) with a hole of approximately 1 cm diameter.
Through this hole an electric prod can be inserted (shock of 20 mA).
After a habituation period of at least aweek the animals were tested in
the middle of the light phase (CT4–CT10). The electric prod is inserted
into the cage and after the ﬁrst shock the behavior of the rat was
monitored for 10 min (Eline software program). The time spent on
exploration of the cage, self-grooming, exploration of the prod,
burying the prod and immobile (freezing) behavior was scored.
2.4. Surgery
All animals were equipped with a double jugular vein catheter.
Rats were sedated using an isoﬂurane-O2/N2O gas anesthesia. Asilicon heart catheter (0.95 mm OD, 0.50 mm ID, and 0.64 mm OD,
0.28 ID) was inserted into the right jugular vein and kept in place
with a ligament. The catheter was pulled under the skin towards the
skull where it was connected to a metal bow. This metal bow was
ﬁxed to the skull with dental cement and 4 small screws. The same
procedure was repeated on the left side. The animals were given
0.1 ml Finadine s.c. for analgesia and 0.25 ml penicillin s.c. to prevent
infection. After surgery the rats were allowed to recover for at least
7 days. During blood sampling or infusions a piece of tubing could be
attached to the metal bow, hereby samples could be taken from
conscious rats. In between experiments, the catheter was ﬁlled
with a PVP/heparin solution preventing blood clot formation in the
catheter [19].
2.5. Intravenous glucose tolerance test
Rats were accustomed to the infusion and blood sample procedure
before the actual onset of the experiments following a standard
procedure described by Steffens [20]. Then, two intravenous glucose
tolerance tests (IVGTT) were performed. During the ﬁrst IVGTT, the
rats were infused with 10 mg/min glucose for 20 min through the
catheter in the left jugular vein, which is a physiological dose that
mimics the glucose response after a meal [21]. The rats were denied
access to their food from the beginning of the light phase until the end
of the IVGTT; food was removed at CT0. The experiments were
performed in themiddle of the light phase, between CT4 and CT6. Two
baseline blood samples were taken before the start of the infusion
(t=−15 and t=−5). During and after infusion (from t=0 to
t=20min) blood samples of 0.2mlwere take at 1, 3, 5, 7,10,15, 20, 23,
26, 30 and 40 min. A total volume of 2.8 ml blood was taken and the
loss of volume was substituted by saline infusion. During the second
IVGTT the rats were infused with 16 mg/ml glucose for 30 min, which
is a higher dose to evoke a larger insulin response, but the levels still
remain within a physiological range [22]. In this experiment, blood
samples were taken at baseline and at 5, 10, 15, 20, 25, 30, 35, 40, and
50 min after the start of the infusion.
Blood samples were kept on ice and stored in tubes with 10 µl
EDTA (0.09 g/ml). For glucose determination 50 µl of blood with
450 µl heparin solution (2%) was stored at −20 °C. The remaining
blood was centrifuged for 15 min and plasma was stored for insulin
determination.
2.6. Post mortem analysis
The rats were sacriﬁced two weeks after the last IVGTT. Three
hours before lights off, blood samples were taken directly from the
heart under isoﬂurane-O2/N2O gas anesthesia for determination of
blood glucose, plasma insulin, and leptin levels. Animals were
hereafter sacriﬁced using an overdose of pentobarbital. Epididymal
and retroperitoneal fat pads and the liverwere taken out andweighed.
Hereafter, biopsies were taken from the liver (left ventral lobe) for
further analysis. The skin with the subcutaneous fat was removed
from the carcass. The liver, skin, and carcasses were dried at 80 °C for
5 days. The fat content was determined by extracting the fat from the
tissue using a petroleum based Soxlet fat extractor. After fat extraction
the tissue was dried for 5 days again. The relation between dry tissue
weight before and after fat extraction provides information on the fat
content of the tissue.
2.7. Plasma fuel and hormone analysis
Plasma levels of insulin and leptin were measured using commer-
cial radioimmunoassay (RIA) kits (Linco Research). Plasma corticoster-
one level were determined with a commercial RIA kit (MP
Biomedicals). Plasma non-esteriﬁed fatty acids, plasma cholesterol
levels, and liver triglyceride levels were measured using commercial
Fig. 1. A: Percentage time spent burying for RLA (n=10, white bars) and RHA (n=10,
black bars) rats in the defensive burying test (F1,15=50.276, Pb0.01). B: Percentage
time spent immobile for RLA and RHA rats in the defensive burying test. ⁎ indicates a
signiﬁcant difference from RLA rats (F1,15=47.266, Pb0.01).
Table 2
Baseline body weight, food intake and water intake of RLA (n=8) and RHA rats (n=8).
RLA RHA
Body weight (g) 410.5±12.5 391.8±9.6
Food intake (kcal/day) 70.8±4.3 67.9±3.4
Water intake (g/day) 40.7±1.49 33.6±1.52a
a Indicates a signiﬁcant difference (F1,15=6.307, Pb0.05).
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ferry-cyanidemethod (Hoffman,1937) in an auto analyzer (Technicon).2.8. Statistical analysis
The data are expressed as averages with standard error of the
mean. Differences in food and water intake, body weight, the
defensive burying test, and baseline plasma levels between selection
lines were determined using a one-way ANOVA. The selection linewas
the between subjects factor. Differences in insulin and glucose levels
before, during, and after the IVGTT were examined using a repeated
measures ANOVA. The selection line was the between subjects factor.
The area under the curves of both glucose and insulin responses were
calculated and reported as the average area under the curve (AUC)
with the standard error of the mean. The differences between theTable 1
Percentage of time spent on other behaviors than burying or immobility during the
defensive burying test of RLA (n=8) and RHA rats (n=8).
RLA RHA
Immobile 65.0±9.9 1.5±1.0a
Bury prod 1.5±0.9 63.7±7.8a
Explore cage 8.0±3.2 16.1±6.2
Explore Prod 12.7±10.2 13.3±4.1
Grooming 12.4±4.0 9.0±4.0
a Indicates a signiﬁcant difference Bury prod (F1,15=50.276, Pb0.01), Immobile
(F1,15=47.266, Pb0.01).selection lines were determined using a one-way ANOVA. A
conﬁdence interval of 5% was used.
3. Results
3.1. Defensive burying test
Fig. 1 shows the behavior of the rats in the defensive burying test
during the ﬁrst 10 min after receiving a shock. RHA rats spent
signiﬁcantly more time burying the prod (F1,15=50.276, Pb0.01) and
displayed signiﬁcantly less immobility behavior than RLA rats
(F1,15=47.266, Pb0.01) (Fig. 1). There were no differences in other
behaviors than burying and immobility (Table 1).
3.2. Body weight, food intake, and water intake
Table 2 displays the body weight, the food intake, and water intake
during the four weeks baseline measurements. There were no
differences in body weight or weight gain between RLAs and RHAs
in the four week baseline period. Food intake was not differentFig. 2. A: Glucose response of RLA (n=12, open symbols) and RHA (n=12, closed
symbol) rats during an intravenous glucose tolerance test. B: Insulin response of RLA
and RHA rats during an intravenous glucose tolerance test. Grey bar indicates infusion of
a 10 mg/min glucose. ⁎ indicates a signiﬁcant difference (F1,15=3.062, Pb0.01).
Fig. 3. A: Glucose response of RLA (n=10, open symbols) and RHA (n=10, closed
symbol rats during an intravenous glucose tolerance test. B: Insulin response of RLA and
RHA rats during an intravenous glucose tolerance test. Grey bar indicates infusion of a
16 mg/min glucose. ⁎ indicates a signiﬁcant difference from the RLA rats (F1,15=3.973,
Pb0.01).
Table 4
Baseline values of blood parameters of RLA (n=8) and RHA rats (n=8).
RLA RHA
Corticosteron (ng/ml) 364.4±42.1 228.5±30.9a
Leptin (ng/ml) 4.46±0.64 3.19±0.76a
Non-esteriﬁed fatty acids (mM) 0.23±0.04 0.19±0.3
Liver triglycerides (g/100 g tissue) 3.5±0.3 2.3±0.3a
Total cholesterol (mM) 1.54±0.17 1.11±0.12a
a Indicates a signiﬁcant difference. Corticosterone (F1,13=6.989, Pb0.01), Leptin
(F1,13=3.156, Pb0.05), total cholesterol (F3,11=2.552, Pb0.05), liver triglycerides
(F3,11=3.214, Pb0.01).
Table 5
Carcass analysis of RLA (n=8) and RHA rats (n=8).
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in RLAs compared with RHAs (F1,15=6.307, Pb0.05).
3.3. IVGTT
Figs. 2A and 3A reveal the blood glucose levels during the 10 and
16 mg/min IVGTT respectively. Blood glucose levels started at a
baseline of approximately 5 mM in both conditions and increased to a
maximum of 7.8 mM (10 mg/min) and 9.6 mM (16 mg/min) during
infusion. After termination of the infusion, blood glucose levels
returned towards baseline levels within 10 min. In both experiments
there were no signiﬁcant differences between RLA and RHA rats.
Figs. 2B and 3B display the plasma insulin levels during the 10 and
16 mg/min IVGTT respectively. In both experiments, baseline plasma
insulin levels were signiﬁcantly higher in RLAs in comparison to the
RHAs. This difference in insulin levels between the RLAs and RHAs
remained signiﬁcant throughout both IVGTT (Pb0.01).
Glucose and insulin responses were also calculated as area under
the curve (AUC), which are presented in Table 3. The AUCs for glucoseTable 3
Area under the curve during an IVGTT in RLA (n=10) and RHA rats (n=10) corrected
for baseline values.
RLA RHA
10% Glucose 130.4±14.0 119.4±5.0
10% Insulin 123.5±25.9 101.4±22.3
16% Glucose 197.1±16.6 196.3±18.8
16% Insulin 344.5±36.6 289.3±27.7a
a Indicates a signiﬁcant difference (F1,19=9.402, Pb0.01).were not different between the RLAs and the RHAs. The AUC for
insulin was signiﬁcantly higher in the RLAs compared to the RHAs
during the 16 mg/min glucose infusion (F1,19=9.402, Pb0.01), the
differences in insulin response during the 10 mg/min infusion just
failed to reach signiﬁcance (P=0.06).
3.4. Post mortem analysis
Table 4 displays the post mortem plasma levels of corticosterone,
leptin, non-esteriﬁed fatty acids (NEFA), total cholesterol, triglycer-
ides, and the body composition of the RLA and RHA rats. Plasma levels
of corticosterone (F1,13=6.989, Pb0.01), leptin (F1,13=3.156, Pb0.05)
total cholesterol (F3,11=2.552, Pb0.05), and levels of triglyceride in
the liver (F3,11=3.214, Pb0.01) were signiﬁcantly higher in RLA rats
than in their RHA counterparts. No signiﬁcant differences were found
in NEFA levels.
Table 5 presents the fat distribution as determined by carcass
analysis. The RLA rats had a signiﬁcantly higher epididymal fat weight
than RHA rats (F1,13=7.564, Pb0.05). There were no signiﬁcant
differences in lean body mass, total fat percentage and retroperitoneal
and subcutaneous fat weight. The results remained the samewhen the
data were corrected for lean body mass or total fat mass.
4. Discussion
In this study we characterized the metabolic proﬁles of Roman
High and Low Avoidance selection lines. RHA and RLA rats were
originally selected and bred for a rapid versus poor acquisition of the
active avoidance response. They differ in emotional reactivity and
coping style. RLA rats are highly emotional individuals with a passive
coping style, whereas RHA rats behave as active individuals with low
emotional reactivity. We hypothesized that due to the increased HPA-
axis activity displayed in the RLA rats these animals could be prone for
the development of the metabolic syndrome.
We found that indeed the passive RLA coping style was associated
with insulin resistance and elevated levels of plasma leptin, FFAs, liver
triglycerides, and an increased visceral fat content. The pro-active RHA
rat revealed no signs of adiposity or insulin resistance. In fact, the
glucose and insulin proﬁles in RHA rats were remarkably similar to
those that were found in numerous previous studies in Wistar rats in
our laboratory throughout the years [21,23,24]. Taken together thisRLA RHA
Body mass 435±14 401±16
Epididymal fat (g) 4.95±0.24 4.10±0.34a
Retroperitoneal fat (g) 7.85±1.42 9.79±1.37
Subcutaneous fat (g) 36.92±1.95 37.66±0.87
Total body fat (%) 11.56±0.55 13.09±1.54
Lean carcass weight (g) 306.2±0.4 293.4±11.6
Ratio epididymal/retroperitoneal 0.64±0.03 0.47±0.03a
The table displays wet fat mass. The total body fat was calculated as a percentage of the
total body mass at sacriﬁce.
aIndicates a signiﬁcant difference (F1,13=7.564, Pb0.05).
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passive coping style might have an increased risk for the development
of metabolic diseases as insulin resistance and the metabolic
syndrome. This means that the Roman Low Avoidance rat may be
considered as a non-obese rat model for insulin resistance.
Plasma corticosterone levels were signiﬁcantly elevated in the RLA
rats. This conﬁrms previous ﬁndings in the literature, in which it was
shown that RLA rats have an increased sensitivity of the hypothala-
mus-pituitary-adrenal (HPA) axis, leading to increased corticosterone
and corticotrophin (ACTH) secretion [10,11].
Increased HPA-axis activity has been reported to be a potent
mediator of insulin resistance [16,25-27]. Patients with Cushing's
syndrome, with an excess of corticosteroids, commonly express severe
insulin resistance [28]. Moreover, humans [29] as well as animals
[16,30] treated with (synthetic) glucocorticoïds develop insulin
resistance. One should note that the phenotype of dexamethasone-
induced insulin resistant rats does not involve an increase in body
mass [31] which is similar to what we observed in the present study.
The mechanism behind glucocorticoïd-induced insulin resistance
has not been fully elucidated, however glucocorticoïd-induced insulin
resistance is generally associated with an impairment of insulin's
actions to suppress hepatic glucose production and to stimulate
glucose utilization [28,32]. Additionally, glucocorticoïds seem to have
a direct inhibitory effect on glucose-induced insulin release in the β-
cells. Corticosteroids have been suggested to induce insulin resistance
via an increase in circulating FFAs. However, dexamethasone-induced
impairment in skeletal muscle glucose transport is not reversed by
inhibition of FFA oxidation [33], indicating that corticosteroids may
have a direct effect on insulin sensitivity. This is conﬁrmed in an
animal model for high fat feeding-induced insulin resistance in
skeletal muscle, where treatment with the anti-glucocorticoïd RU-486
resulted in an amelioration of insulin resistance [34].
The RLA rats display a differential fat distribution, favoring visceral
fat. Carcass analysis showed a small but signiﬁcant difference in body
composition: epididymal adiposity was higher in RLA rats than in RHA
rats. There are numerous studies that suggest that there is a direct
relation between the amount of visceral adiposity and the severity of
insulin resistance (reviewed in [13]). Likewise, removal of visceral fat
in obese hepatic insulin resistant rats reverses insulin resistance [25].
The observed increased epididymal fat mass might therefore have
inﬂuenced the insulin levels in the RLA rats (or vice versa). The
underlying mechanism remains under debate, however, there is
evidence that increased HPA-axis activity plays a part.
Olefsky et al. [35] have shown that the visceral adiposites display
higher densities of glucocorticoïd receptors than adiposites from the
subcutaneous depots. This has lead to the hypothesis that a fat
distribution favoring visceral adiposites in combination with elevated
levels glucocorticoïds may have exacerbate the shift of lipids to the
skeletal muscles [36]. In turn, elevated lipids levels in the skeletal
muscles are associated with increased insulin resistance [37].
Interestingly, increased portal venous supply of long-chain fatty
acids from the visceral fat depots to the liver induces HPA-axis
activation, thus amplifying this process [26]. Based on these data, we
might conclude that in the RLA rats the increased epididymal fat depot
in interplay with high levels of glucocorticoïds may have led to the
observed increased in baseline insulin levels and increased insulin
resistance.
Plasma levels of leptin were also elevated in the RLA rats,
consistent with the differences in insulin but inconsistent with the
ﬁnding that are no major differences in fat mass between RLAs and
RHAs. This is surprising, and might be explained by a direct effect of
elevated insulin levels on leptin production [38,39].
In summary, this study showed that the coping style of an
individual is clearly associated with particular metabolic and
(patho)physiological characteristics. The highly emotional, passively
coping Roman Low Avoidance rats show insulin resistance already atnormal weight. The RLA rat may therefore be considered as a (non-
obese) animal model for insulin resistance under standard chow
conditions. These standard chow conditions are important since Rossi
et al. [12] have already shown that RLA rats are highly susceptible for
weight gain on a high fat diet. Our future studies will therefore
primarily focus on the effect of the interaction between a passive
coping style and changing dietary conditions on the susceptibility for
diseases like insulin resistance, type 2 diabetes mellitus, and the
metabolic syndrome.
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